Xencor | XNCR - DETTE





DETTE Changement Date
AbbVie USD 72.86B 5.36B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 57.32B 2.72B 2026-03
Arrowhead Research USD 983.69M 5.77M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
J&J USD 54.99B 7.05B 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 36.51M 500K 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Xencor USD 175.16M 12.58M 2026-03